Haemonetics (HAE) Tops Q2 EPS by 11c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.78 +0.34%
EPS Growth %: -0.9%
Financial Fact:
Net income: 19.83M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -0.9%
Financial Fact:
Net income: 19.83M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.62, $0.11 better than the analyst estimate of $0.51. Revenue for the quarter came in at $209 million versus the consensus estimate of $207.65 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cal-Maine Foods adds two independent directors, expanding board to ten
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
